KAYLA GINTER: Open Payments
NPI 1669219481 · SUN CITY CENTER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $217 |
| Neurocrine BioSciences, Inc. | 2 | $150 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, SPRAVATO, CAPLYTA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
